Aravive warns of possible liquidation as it axes all clinical work, lays off 70% of employees
Things are going downhill fast at Aravive in the wake of a Phase III flop. As the negative results in ovarian cancer quashed hopes of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
